Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-15 · accession 0001882909-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | 2025-12-15 | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $36.00 | -2,910 | 45.6K | -6% | -$104.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | S | D | 2,910 | $36.00 | 45,635 | D | — | — |